Tamoxifen: a caveat on the con side of the debate.

dc.contributor.authorMoser, S M
dc.date.accessioned2019-07-02T16:10:55Z
dc.date.available2019-07-02T16:10:55Z
dc.date.issued1993-04
dc.identifier.issn0017-8594
dc.identifier.pubmed8500988
dc.identifier.urihttp://hdl.handle.net/10524/62578
dc.language.isoeng
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshBreast Neoplasms/prevention & control
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshMiddle Aged
dc.subject.meshRisk Factors
dc.subject.meshTamoxifen/adverse effects/therapeutic use
dc.titleTamoxifen: a caveat on the con side of the debate.
dc.typeClinical Trial
dc.typeJournal Article
dc.type.dcmiText
prism.number4
prism.pagerange87-8, 102
prism.publicationnameHawaii medical journal
prism.volume52

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
1993-04p87-102.pdf
Size:
358.21 KB
Format:
Adobe Portable Document Format